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Available online 22 August 2014A 9-month-old girl was admitted with fever and rash. After
onset of fever with cough 1 week ago, a skin rash appeared
which started from the trunk and then spread to the scalp
and extremities. Although the rash was initially in a
configuration of common and nonmerger papules on sig-
nificant erythematous grounds, it had become itchy and
started to peel within a few days. The patient was evalu-
ated by a dermatologist, and the rash was considered as an
eczematous lesion prior to application. On physical exam-
ination, there were scaly maculopapular lesions which were
scattered throughout the body with yellow reflections and
tending to coalesce in the extremities without any oral or
other mucosal changes (Figures 1 and 2). General condition
was good, all other system examinations were normal
except oropharyngeal hyperemia. Hemoglobin was 11 g/dL
(N: 11e14.5), white blood cell (WBC) count was 33,200/
mm3 (N: 3400e9500) and platelets were 449,000/mm3 (N:
150,000e450,000). In a peripheral blood smear 68%
neutrophil cells were detected. Erythrocyte sedimentation
rate was 29 mm/hour (N: 0e20) and C-reactive protein
3.9 mg/dL (N: 0e0.8) with normal values of biochemical
parameters. The baby was hospitalized because of reluc-
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1875-9572/Copyright ª 2014, Taiwan Pediatric Association. Published bceftriaxone was started. The blood culture taken before
treatment was positive for beta-hemolytic Streptococcus
group A sensitive to current treatment. The patient was
afebrile and the rash began to fade after initiation of
treatment. On the 7th day of treatment acute phase re-
actants returned to normal and the control blood culture
was negative. The patient was discharged in a normal
condition with hyperpigmentation and desquamation in
rash areas. Streptococcal diseases occur primarily amongFigure 1 Scaly maculopapular lesions on the trunk along with
mild erythematous grounds.
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Figure 2 Common and merger maculopapular lesions on
erythematous grounds on the left arm with desquamation in
some places.
496 S. Kanik-Yuksek et alchildren aged 5e15 years.1 Scarlet fever, which is a type of
streptococcal disease and originates from streptococcal
erythrogenic toxins, is rare before the age of 2 years due to
the presence of maternal antiexotoxin antibodies and lack
of previous sensitization.2,3 This case was presentedbecause of beta-hemolytic Streptococci bacteremia and
scarlet fever-like exanthema without typical skin manifes-
tations such as perioral pallor or Pastia lines which is rare in
infancy that could be mistaken for eczema.Conflicts of interest
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